Toggle Main Menu Toggle Search

Open Access padlockePrints

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology

Lookup NU author(s): Professor Alastair GreystokeORCiD, Professor Deborah TweddleORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© Crown 2025.Background: The Experimental Cancer Medicine Centre (ECMC) Network supports UK-wide access to experimental cancer therapies, many of which require specific genomic alterations. This study aimed to develop expert consensus on essential genes for a pan-cancer sequencing panel, involving subject matter experts (SMEs) from the ECMC Network and the pharmaceutical industry. Methods: A pilot with 8 SMEs graded 526 genes, refining the list to 210. A three-round Delphi process was then used, with SMEs iteratively evaluating each gene. In the final round, SMEs also assessed the inclusion of tumour mutational burden (TMB), microsatellite instability (MSI), and mutation types (structural variations, copy number variations, and/or fusions). Results: Consensus was reached on a final panel of 99 genes applicable across multiple cancers. High agreement was also achieved for including TMB, MSI, and screening for structural variations, copy number variants, and fusions. The panel is intended for both adult and paediatric tumour types. Conclusions: This consensus-based gene panel offers a standardised approach to pan-cancer genomic screening. It supports harmonised diagnostics and could improve patient access to personalised therapies and research trials across clinical and NHS settings.


Publication metadata

Author(s): Phillips R, Basu B, Butt Z, Beloueche M, Cook N, Crabb SJ, Greystoke A, Hargrave D, Jones R, Kureeman MY, Lopez J, McKeeve C, Meissner M, O'Carrigan B, Parkes EE, Ronghe M, Roxburgh P, Sarker D, Savage KI, Shaw PHS, Symeonides S, Tweddle DA, Vedi A, Walter HS, Zabkiewicz J, Middleton GW, Beggs AD

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2025

Pages: epub ahead of print

Online publication date: 08/11/2025

Acceptance date: 23/10/2025

Date deposited: 27/11/2025

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41416-025-03252-6

DOI: 10.1038/s41416-025-03252-6

Data Access Statement: The datasets generated and/or analysed during the current study comprise aggregate Delphi survey responses from academic experts. These data are not publicly available due to the confidential nature of expert responses and the terms of participant consent, but anonymised data are available from the corresponding author on reasonable request

PubMed id: 41206382


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cancer Research UK
Little Princess Trust
National Institute for Health and Care Research

Share